Tech Company Financing Transactions
Creyon Bio Funding Round
Creyon Bio closed a $40 million funding round on 3/8/2022. Investors included Data Collective, Lux Capital and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
3/8/2022
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Data Collective (Lead Investor) (Kiersten Stead)
Lux Capital (Lead Investor) (Zavain Dar)
Proceeds Purpose
The funding supports continued optimization of the Creyon Platform, expanding the team, and laying the foundations for a diverse internal pipeline.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for generating uniquely powerful datasets and developing machine learning models to uncover the engineering principles that make precision oligonucleotide-based medicines possible for patient populations of all sizes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Hart
Chief Medical Officer
David Dimmock
Chief Scientific Officer
Swagatam Mukhopadhyay
Chief Technical Officer
Monica McArthur
VP - Bus. Development
Nathan Billings
Browse more venture capital transactions:
Prev: 3/8/2022: Dianthus venture capital transaction
Next: 3/8/2022: Big Bold Health venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs